Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | GPX4 | P36969 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29463888 | 1.00 | DNM1 (0.34) | DNM1CNR1CNR2HTTTLR8 | |
| SCHEMBL30726899 | 0.83 | KDM4E (0.33) | HTTTLR8KDM4ETP53TDP1 | |
| SCHEMBL136071 | 0.83 | KDM4E (0.33) | HTTTLR8KDM4ETP53TDP1 | |
| SCHEMBL29575251 | 0.81 | DNM1 (0.36) | DNM1HTTALDH1A1TP53 | |
| SCHEMBL628134 | 0.81 | DNM1 (0.36) | DNM1HTTALDH1A1TP53 | |
| SCHEMBL141521 | 0.78 | TP53 (0.33) | TP53TDP1 | |
| SCHEMBL29463885 | 0.78 | TP53 (0.33) | TP53TDP1 | |
| Trimethylammonium SCHEMBL5084815 | 0.77 | TDP1 (0.41) | NPC1ALDH1A1TP53RAB9ATDP1 | |
| Trimethylammonium SCHEMBL31200790 | 0.77 | TDP1 (0.41) | NPC1ALDH1A1TP53RAB9ATDP1 | |
| SCHEMBL4454308 | 0.77 | PDE5A (0.33) | CNR1CNR2HTTTLR8KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4685217-A1 | AQUEOUS LUBRICANT COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4043500-B1 | ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250197621-A1 | THERMOPLASTIC RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-3124505-B1 | ETHYLENE/ALPHA-OLEFIN COPOLYMER AND LUBRICATING OIL | MITSUI CHEMICALS INC (JP) | 2025-03-19 | — | — | EP | disclosed |
| US-12221529-B2 | Ethylene copolymer composition and use thereof | MITSUI CHEMICALS, INC. (JP) | 2025-02-11 | — | — | US | disclosed |
| EP-4495182-A1 | THERMOPLASTIC RESIN COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-20240352253-A1 | RESIN COMPOSITION AND USE THEREOF | MITSUI CHEMICALS, INC. (JP) | 2024-10-24 | — | — | US | disclosed |
| WO-2024195445-A1 | AQUEOUS LUBRICANT COMPOSITION | 三井化学株式会社 | 2024-09-26 | — | — | WO | disclosed |
| EP-4435047-A1 | RESIN COMPOSITION AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2024-09-25 | — | — | EP | disclosed |
| EP-4417648-A1 | ETHYLENE COPOLYMER COMPOSITION AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2024-08-21 | — | — | EP | disclosed |
| US-20070100056-A1 | Process for producing thermoplastic resin composition | MITSUI CHEMICALS, INC. (JP) | 2007-05-03 | — | — | US | disclosed |
| US-20070080483-A1 | Process for producing injection molded product | MITSUI CHEMICALS, INC. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070082998-A1 | Process for producing injection molded product | MITSUI CHEMICALS, INC. (JP) | 2007-04-12 | — | — | US | disclosed |
| EP-1731533-A1 | PROCESS FOR PRODUCING OLEFIN POLYMER | Mitsui Chemicals, Inc. (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-20060270812-A1 | Copolymerizing ethylene is solution at 120-300 degrees C., with a diarylmethylene- or diarylsilylene-bridged metallocene catalyst and an organoaluminum compound, an alumoxane, or a compound which reacts with the bridged metallocene to form an ion pair; narrow molecular weight distribution. | MITSUI CHEMICALS, INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| US-20060116303-A1 | decene-ethylene copolymer, zirconium, titanium or hafnium fluorene-containing complexes, organometallics; improved high thermal oxidation stability, viscosity index, low-temperature viscosity properties and shear stability | MITSUI CHEMICALS, INC. (JP) | 2006-06-01 | — | — | US | disclosed |
| EP-1661921-A1 | Synthetic lubricating oil and lubricating oil composition thereof | Mitsui Chemicals, Inc. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1640385-A2 | Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor | MITSUI CHEMICALS, INC. (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050131171-A1 | Process for preparing low molecular weight olefin (CO) polymer and polymerization catalyst used therefor | MITSUI CHEMICALS, INC. (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1416000-A1 | Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor | Mitsui Chemicals, Inc. (JP) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131171-A1 | Process for preparing low molecular weight olefin (CO) polymer and polymerization catalyst used therefor | CYP4F11, WEE2, FAR1 | DNM1 1191/4885CNR1 1239/4885CNR2 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.